# The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age

> **NCT01306006** · PHASE4 · COMPLETED · sponsor: **Bandim Health Project** · enrollment: 3500 (estimated)

## Conditions studied

- Mortality
- Vaccines

## Interventions

- **BIOLOGICAL:** Providing measles vaccine for all children 9-35 months who have not yet received a routine measles vaccine

## Key facts

- **NCT ID:** NCT01306006
- **Lead sponsor:** Bandim Health Project
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2017-12-02
- **Final completion:** 2017-12-02
- **Target enrollment:** 3500 (ESTIMATED)
- **Last updated:** 2026-02-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01306006

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01306006, "The Effect on Overall Mortality of a National Policy of Limiting Measles Vaccination to Children Below 12 Months of Age". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01306006. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*